Oneness Biotech Co., Ltd. (LUX:ONEA)
10.60
+0.20 (1.92%)
At close: Apr 2, 2025
Oneness Biotech Revenue
In the year 2024, Oneness Biotech had annual revenue of 117.93M TWD with 35.89% growth. Oneness Biotech had revenue of 31.41M in the quarter ending December 31, 2024, with 22.32% growth.
Revenue
117.93M TWD
Revenue Growth
+35.89%
P/S Ratio
n/a
Revenue / Employee
2.74M TWD
Employees
43
Market Cap
929.97M EUR
Revenue Chart
* This company reports financials in TWD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 117.93M | 31.14M | 35.89% |
Dec 31, 2023 | 86.78M | -978.77M | -91.86% |
Dec 31, 2022 | 1.07B | 999.79M | 1,520.24% |
Dec 31, 2021 | 65.77M | 24.16M | 58.07% |
Dec 31, 2020 | 41.61M | 28.13M | 208.76% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reinet Investments S.C.A. | 1.04B |
Luxempart | 50.29M |
CPI FIM | 147.67M |
Socfinasia | 178.94M |
Socfinaf | 550.77M |
Velcan Holdings | 3.01M |
GP Investments | 96.12M |